Thalidomide and thromboprophylaxis for dermatologic indications: An unmet need for more evidence

Anuradha Bishnoi¹, Vaneet Singh², Sanjeev Handa¹, Keshavamurthy Vinay³

Affiliations

¹ Department of Dermatology Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
² Sanjivni Eye Institute, Ambala, India.
³ Department of Dermatology Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Electronic address: vinay.keshavmurthy@gmail.com.

PMID: 29733936
DOI: 10.1016/j.jaad.2018.04.048

Comment

Thalidomide and thromboprophylaxis for dermatologic indications: An unmet need for more evidence

Anuradha Bishnoi et al. J Am Acad Dermatol. 2018 Sep.

. 2018 Sep;79(3):e45-e46.

doi: 10.1016/j.jaad.2018.04.048. Epub 2018 May 4.

Authors

Anuradha Bishnoi¹, Vaneet Singh², Sanjeev Handa¹, Keshavamurthy Vinay³

Affiliations

¹ Department of Dermatology Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
² Sanjivni Eye Institute, Ambala, India.
³ Department of Dermatology Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Electronic address: vinay.keshavmurthy@gmail.com.

PMID: 29733936
DOI: 10.1016/j.jaad.2018.04.048

No abstract available

PubMed Disclaimer

Comment in

Thromboprophylaxis and thalidomide in the noncancer setting: Toward an algorithm that is based on patient risk factors and underlying disease?
Chasset F, Arnaud L, Francès C. Chasset F, et al. J Am Acad Dermatol. 2018 Sep;79(3):e47-e48. doi: 10.1016/j.jaad.2018.04.049. Epub 2018 May 5. J Am Acad Dermatol. 2018. PMID: 29733935 No abstract available.

Comment on

Efficacy and tolerance profile of thalidomide in cutaneous lupus erythematosus: A systematic review and meta-analysis.
Chasset F, Tounsi T, Cesbron E, Barbaud A, Francès C, Arnaud L. Chasset F, et al. J Am Acad Dermatol. 2018 Feb;78(2):342-350.e4. doi: 10.1016/j.jaad.2017.09.059. Epub 2017 Oct 5. J Am Acad Dermatol. 2018. PMID: 28989111
Risk of thromboembolic events in patients treated with thalidomide for cutaneous lupus erythematosus: A multicenter retrospective study.
Cesbron E, Bessis D, Jachiet M, Lipsker D, Cordel N, Bouaziz JD, Bagot M, Arnaud L, Barbaud A, Francès C, Chasset F; Study Group of Systemic Diseases in Dermatology (Étude des Maladies Systémiques en Dermatologie). Cesbron E, et al. J Am Acad Dermatol. 2018 Jul;79(1):162-165. doi: 10.1016/j.jaad.2018.02.049. Epub 2018 Mar 1. J Am Acad Dermatol. 2018. PMID: 29496481 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Thalidomide and thromboprophylaxis for dermatologic indications: An unmet need for more evidence

Affiliations

Thalidomide and thromboprophylaxis for dermatologic indications: An unmet need for more evidence

Authors

Affiliations

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical